ProPhase Labs Inc (PRPH) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $0.01 (+4.96%), Market cap $0.00B, 52-week low–high $0.07 ~ $0.97.
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tes
Financial statements, price targets, institutional (13F) holdings and related news for ProPhase Labs Inc are updated in real time on BlackAll Trade.
ProPhase Labs Inc trades at $0.01 (+4.96%). Real-time quotes and charts are available on BlackAll Trade.
ProPhase Labs Inc has a market cap of about $0.00B.
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The c